University of Sussex
Browse
Commentary Integrating electrodermal biofeedback into pharmacologic treatment of grand mal seizures.pdf (222.93 kB)

Commentary: Integrating electrodermal biofeedback into pharmacologic treatment of grand mal seizures

Download (222.93 kB)
journal contribution
posted on 2023-06-09, 07:00 authored by Iliana Kotwas, Jean-Arthur Micoulaud-Franchi, Fabrice Bartolomei, Yoko NagaiYoko Nagai
Thirty percent of patients with epilepsy experience seizures despite optimal anticonvulsant drug treatment. Stress is frequently identified by patients with epilepsy as a precipitant of seizures (Spector et al., 2000; Ferlisi and Shorvon, 2014). Patients also often report using countermeasures to control the seizure onset. These are typically spontaneous and individualized such as increasing arousal by walking, breathing, standing, focusing attention, changing way of thinking, and more rarely inducing relaxation (Lee and No, 2005; Hether et al., 2013). In parallel, behavioral and psychological interventions, complementing conventional therapeutic methods for the management of epileptic seizures, have gained greater clinical attention over the past decade. Among these, Biofeedback (BFK) represents a noninvasive biobehavioral treatment that enables a patient to gain volitional control over a specific physiological process. BFK has already shown its value when applied to patients with epilepsy (Sterman and Friar, 1972; Rockstroh et al., 1993; Nagai et al., 2004a; Nagai, 2011; Micoulaud-Franchi et al., 2014a,b). Scrimali et al. (2015) have rightly pointed out the potential usefulness of electrodermal biofeedback in the management of refractory epilepsy. In a single case study, they report an effect of electrodermal activity (EDA) relaxation biofeedback in reducing seizures in a patient treated for 2 years. This case study supports the necessity to expand clinical armamentarium for treatment-resistant patients with few alternatives.

History

Publication status

  • Published

File Version

  • Published version

Journal

Frontiers in Human Neuroscience

ISSN

1662-5161

Publisher

Frontiers Media

Volume

9

Department affiliated with

  • BSMS Neuroscience Publications

Full text available

  • Yes

Peer reviewed?

  • Yes

Legacy Posted Date

2017-07-05

First Open Access (FOA) Date

2017-07-05

First Compliant Deposit (FCD) Date

2017-07-05

Usage metrics

    University of Sussex (Publications)

    Categories

    No categories selected

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC